Compare Abeona Therapeutics Inc (ABEO) vs Invesco WilderHill Clean Energy ETF (PBW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Abeona Therapeutics Inc trades at $6.71 (market cap $373.32M), while Invesco WilderHill Clean Energy ETF trades at $34.76. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Invesco WilderHill Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | PBW | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.23 | $46.99 |
52-Week Low | $4.17 | $21.70 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
PBW trades at $37.52, up 2.57% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF lacks key valuation metrics like P/E and P/S, and recent news highlights its volatility tied to interest rates and clean energy sector momentum. A dividend of $0.24 is scheduled for June 2026, but financial statements for the current period are unavailable.
The outlook is cautious due to bearish technicals and sensitivity to Treasury yields, though clean energy tailwinds from energy security concerns offer potential. Risks include rate cycle volatility and sector competition, with investor sentiment mixed amid Nasdaq pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →
